One Cheap Drug Turns Out to Save COVID Patients’ Lives
By News
Published 4 years ago on
June 16, 2020
Share
[aggregation-styles]
Bloomberg Subscription
A low-cost, widely used anti-inflammatory drug improved survival in patients with COVID-19, the first treatment to show life-saving promise months into the pandemic.
Deaths among patients who needed breathing assistance were lower over a period of four weeks when they received the 60-year-old medicine dexamethasone, University of Oxford researchers said Tuesday. The study was stopped early because of its crucial findings.
Doctors and companies are scouring for treatments that can help patients survive the new coronavirus, which has killed more than 400,000 people worldwide. Gilead Sciences Inc.’s antiviral remdesivir, which has approval to treat COVID-19, has only demonstrated the ability to shorten patients’ recovery.
Read More →
Bloomberg Subscription
A low-cost, widely used anti-inflammatory drug improved survival in patients with COVID-19, the first treatment to show life-saving promise months into the pandemic.
Deaths among patients who needed breathing assistance were lower over a period of four weeks when they received the 60-year-old medicine dexamethasone, University of Oxford researchers said Tuesday. The study was stopped early because of its crucial findings.
Doctors and companies are scouring for treatments that can help patients survive the new coronavirus, which has killed more than 400,000 people worldwide. Gilead Sciences Inc.’s antiviral remdesivir, which has approval to treat COVID-19, has only demonstrated the ability to shorten patients’ recovery.
Read More →
RELATED TOPICS:
Categories
Latest
Videos
Crime /
16 hours ago
Thief Uses Sleight of Hand to Swipe $255K Tiffany Ring, Cops Say
Water /
16 hours ago
California Reports the First Increase in Groundwater Supplies in 4 Years
Crime /
17 hours ago
Lawsuit Alleges Decades of Child Sex Abuse at Illinois Juvenile Detention Centers Statewide
Crime /
17 hours ago
